A patent problem called anthrax
The Canadian government's decision to manufacture the generic version of the antibiotic drug, Ciprofloxacin, has expectedly met with no voice of dissent from the patent holding MNC. Even the US
The Canadian government's decision to manufacture the generic version of the antibiotic drug, Ciprofloxacin, has expectedly met with no voice of dissent from the patent holding MNC. Even the US